Evidence map›Paper›PMID 35681652›Full record

ReviewCancers2022

Concomitant Hepatic Artery Resection for Advanced Perihilar Cholangiocarcinoma: A Narrative Review.

Takehiro Noji, Satoshi Hirano, Kimitaka Tanaka, Aya Matsui, Yoshitsugu Nakanishi, Toshimichi Asano, Toru Nakamura, Takahiro Tsuchikawa

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Takehiro NojiDepartment of Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Sapporo City 060-8638, Japan.ORCID 0000-0003-3048-0685
Satoshi HiranoDepartment of Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Sapporo City 060-8638, Japan.
Kimitaka TanakaDepartment of Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Sapporo City 060-8638, Japan.ORCID 0000-0001-9899-4581
Aya MatsuiDepartment of Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Sapporo City 060-8638, Japan.
Yoshitsugu NakanishiDepartment of Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Sapporo City 060-8638, Japan.
Toshimichi AsanoDepartment of Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Sapporo City 060-8638, Japan.
Toru NakamuraDepartment of Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Sapporo City 060-8638, Japan.
Takahiro TsuchikawaDepartment of Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Sapporo City 060-8638, Japan.
Hokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perihilar cholangiocarcinoma (PHCC) is one of the most intractable gastrointestinal malignancies. These tumours lie in the core section of the biliary tract. Patients who undergo curative surgery have a 40-50-month median survival time, and a five-year overall survival rate of 35-45%. Therefore, curative intent surgery can lead to long-term survival. PHCC sometimes invades the surrounding tissues, such as the portal vein, hepatic artery, perineural tissues around the hepatic artery, and hepatic parenchyma. Contralateral hepatic artery invasion is classed as T4, which is considered unresectable due to its "locally advanced" nature. Recently, several reports have been published on concomitant hepatic artery resection (HAR) for PHCC. The morbidity and mortality rates in these reports were similar to those non-HAR cases. The five-year survival rate after HAR was 16-38.5%. Alternative procedures for arterial portal shunting and non-vascular reconstruction (HAR) have also been reported. In this paper, we review HAR for PHCC, focusing on its history, diagnosis, procedures, and alternatives. HAR, undertaken by established biliary surgeons in selected patients with PHCC, can be feasible.

Indexed as

concomitant hepatic artery resectionperihilar cholangiocarcinomaprognosis

Identifiers

PMID35681652
PMCPMC9179358
OpenAlexW4281691110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.